Dimethyl fumarate attenuates cadmium-induced neurobehavioural deficits, NF-κB/NLRP3-associated neuroinflammation and synaptic protein alterations in rats.
It is indicated that DMF reduces CdCl₂-induced neurobehavioural and molecular toxicity in association with suppression of NF-κB/NLRP3-associated inflammatory signalling and preservation of neurotrophic and synaptic protein profiles.